What is CTTH's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.00B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for CTTH?

P/E (TTM) is n/a and 52-week range is $0.04 to $0.10 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s CTTH figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for CTTH?

The company profile lists net income (TTM) near -$5M, EPS (TTM) near -$0.08 when available from the market-data feed. Figures are informational and may lag live markets.

Where is CTT Pharmaceutical Holdings Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Tampa, Florida, US, 59.7M shares outstanding, ISIN US12651E1064 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

CTT Pharmaceutical Holdings Inc

$CTTH

Health Care · Pharmaceuticals

Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

CTT Pharmaceutical Holdings, Inc. engages in the development of drug delivery systems technology within the pharmaceutical industry. The company is headquartered in Tampa, Florida. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The company rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. The company offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. The company is a thin film for treating dogs and cats.

Website

www.cttpharmaceuticals.com/

IPO

1997-04-18

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)